<DOC>
	<DOCNO>NCT01291732</DOCNO>
	<brief_summary>The Aim study evaluate safety , tolerability , pharmacokinetics pharmacodynamics Asian healthy male administer single dose BI 135585 .</brief_summary>
	<brief_title>Single Rising Dose Study BI 135585 XX Health Asian Male Volunteers .</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male volunteer , 2 . Chinese Japanese ethnicity Exclusion criterion : 1 . Any finding medical examination ( include blood pressure ( BP ) , pulse rate ( PR ) electrocardiogram ( ECG ) ) deviate normal clinical relevance accord investigator medical judgement 2 . Any evidence clinically relevant concomitant disease 3 . Intake drug long half life ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>